Sleep Disorders
Conditions
Interventions
Group A:Ric group
Sponsors
Weihai Municipal Hospital
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1)Age 30-70 years; (2)sleep disorders, including insomnia, sleep-wake disorders, and COVID-19-sleep disorders; (3)Voluntary informed consent.
Exclusion criteria
Exclusion criteria: (1)chronic insomnia according with the diagnostic criteria of Chinese Adult Insomnia Diagnosis and Treatment Guidelines (2017 version); (2)received physical or drug therapy related to sleep disorders before enrollment; (3)intracranial hemorrhage (parenchymal hemorrhage, subarachnoid hemorrhage, subdural/epidural hemorrhage) within 3 months; (4)severe trauma within 30 days; (5)retinal hemorrhage or visceral hemorrhage within 30 days; (6)progressive neurological function deteriorate within 24 hours; (7)major surgery (including femoral, heart, aortic, or carotid surgery) expected within 30 days prior to enrollment or within 3 months after enrollment; (8)fever within 1 week before enrollment; (9)severe uncontrolled hypertension (systolic blood pressure > 180mmHg or diastolic blood pressure > 110mmHg after medication); (10)history of severe cardiac disease, such as rheumatic mitral or aortic stenosis, prosthetic heart valves, atrial fibrillation, atrial flutter, sick sinus syndrome, left atrial myxoma, patent foramen ovale, left ventricular wall thrombus or valve vegetation, congestive heart failure, bacterial endocarditis, or any other cardiovascular condition that was ineligible for enrollment; (11)intracranial tumors or brain aneurysm, arteriovenous malformation history; (12)severe blood system diseases or severe coagulation dysfunction; (13)hyperthyroidism or hypothyroidism; (14)tumors or immune diseases; (15)dementia; (16)the laboratory inspection index is not qualified: Aspartate aminotransferase or alanine aminotransferase was 3 times higher than the upper limit of normal; Creatinine clearance 265umol/l (> 3.0mg/dl); Platelet < 100×109/L; (17)severe soft tissue injury, fracture or vascular injury in the upper limb, peripheral vascular disease in the distal upper limb, etc.; (18)pregnant or lactating women; (19)unwilling to be followed up or poor treatment compliance; (20)participating in other clinical investigators, or have participated in other clinical investigators within 3 months before enrollment; (21)other conditions considered by the investigator to be ineligible for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive;Depression;Anxiety;Sleep quality;Sleepiness;Fatigue; | — |
Countries
China
Contacts
Public ContactZhang Jinbiao
Weihai Municipal Hospital
Outcome results
None listed